Ultralife Corporation
ULBI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $123,335 | $111,554 | $62,243 | $96,863 |
| - Cash | $6,854 | $10,278 | $5,713 | $8,413 |
| + Debt | $54,252 | $29,162 | $23,512 | $23,467 |
| Enterprise Value | $170,733 | $130,438 | $80,042 | $111,917 |
| Revenue | $164,456 | $158,644 | $131,840 | $98,267 |
| % Growth | 3.7% | 20.3% | 34.2% | – |
| Gross Profit | $42,314 | $39,200 | $29,400 | $24,642 |
| % Margin | 25.7% | 24.7% | 22.3% | 25.1% |
| EBITDA | $14,398 | $15,044 | $4,964 | $3,630 |
| % Margin | 8.8% | 9.5% | 3.8% | 3.7% |
| Net Income | $6,312 | $7,197 | -$119 | -$234 |
| % Margin | 3.8% | 4.5% | -0.1% | -0.2% |
| EPS Diluted | 0.38 | 0.44 | -0.007 | -0.015 |
| % Growth | -13.6% | 6,045.9% | 49.3% | – |
| Operating Cash Flow | $16,636 | $1,929 | -$1,263 | $4,325 |
| Capital Expenditures | -$1,932 | -$2,552 | -$1,679 | -$2,814 |
| Free Cash Flow | $14,704 | -$623 | -$2,942 | $1,511 |